Alex Brill to FTC: Claims That PBMs Raise Drug Prices are Unfounded MGA’s Alex Brill submitted a letter in response to a request for information from the Federal Trade Commission. The FTC was looking for information regarding the business practices of pharmacy benefit...
New Report from MGA Examines Impact of Rebates on Drug Pricing, Competition MGA has released a new report today, “Understanding Drug Rebates and Their Role in Promoting Competition,” authored by founder and CEO Alex Brill. Offering new analysis on the...
Patent Thickets Constrain US Biosimilars Market Alex Brill and Christy Robinson | BioProcess International Biosimilars represent a significant cost-savings opportunity in the United States because they can introduce competition for some of the most expensive and...
Teva Economic Impact Report This report, from Matrix Global Advisors (MGA), highlights Teva’s impact on economies in 15 of the 60 countries in which Teva operates. These 15 countries comprise 60 percent of Teva’s total global workforce and 75 percent of revenues in...
The Tax Benefits of Parenthood: A History and Analysis of Current Proposals Alex Brill, Kyle Pomerleau and Grant M. Seiter | AEI Report Executive Summary Since 1917, tax filers with children have received ever-increasing federal income tax benefits. The tax benefits...
New MGA Report on the Potential Savings from Accelerating US Approval of Complex Generics Matrix Global Advisors (MGA) today released a new report, “Potential Savings from Accelerating US Approval of Complex Generics,” by MGA founder and CEO Alex Brill....
